CIK 0001540013
QIPT Quipt Home Medical Corp.
Insider trading from SEC Form 4. Last filing Mar 16, 2026.
Quipt Home Medical Corp. (QIPT) has 19 SEC Form 4 filings on file from 9 insiders, the latest filed on Mar 16, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 open-market trade has been scored at QIPT. The newest: Patrick Dennis Gamble (Exec VP Operations) bought $42k of stock on Dec 26, 2024, filed Dec 30, 2024, scored 31 (weak).
Last 90 days
Signals
Open-market buys and sells at Quipt Home Medical Corp., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Patrick Dennis Gamble Exec VP Operations buy | $42k 17,000 shares | +74% | - |
Transactions
Every row filed, 45 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | David Bachelder Exec. VP Operations | DDisposition to issuer Common Shares | -22,156 | $3.65 | $81k | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Kevin A. Carter director | DDisposition to issuer Common Shares | -201,160 | $3.65 | $734k | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Brian Joseph Wessel director | DDisposition to issuer Common Shares | -116,854 | $3.65 | $427k | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Gregory John Crawford President/CEO | DDisposition to issuer Common Shares | -3,351,196 | $3.65 | $12M | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Thomas Roehrig Chief Accounting Officer | DDisposition to issuer Common Shares | -173,000 | $3.65 | $631k | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Patrick Dennis Gamble Exec. VP Operations | DDisposition to issuer Common Shares | -60,057 | $3.65 | $219k | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Mark Alan Miles Chief Compliance Officer | DDisposition to issuer Common Shares | -110,000 | $3.65 | $402k | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Mark Alan Greenberg director | DDisposition to issuer Common Shares | -435,457 | $3.65 | $1.6M | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Hardik Mehta Chief Financial Officer | DDisposition to issuer Common Shares | -366,471 | $3.65 | $1.3M | 0 | Mar 16, 2026 |
| Mar 16, 2026 | David Bachelder Exec. VP Operations | DDisposition to issuer Stock Option (Right to Buy)derivative | -50,000 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Brian Joseph Wessel director | DDisposition to issuer Common Sharesindirect: By Trust | -98,875 | $3.65 | $361k | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Thomas Roehrig Chief Accounting Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -50,000 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Mark Alan Miles Chief Compliance Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Hardik Mehta Chief Financial Officer | DDisposition to issuer Common Sharesindirect: By Trust | -884,199 | $3.65 | $3.2M | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Mark Alan Greenberg director | DDisposition to issuer Stock Option (Right to Buy)derivative | -428,750 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Patrick Dennis Gamble Exec. VP Operations | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,000 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Gregory John Crawford President/CEO | DDisposition to issuer Common Sharesindirect: By Spouse | -22,500 | $3.65 | $82k | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Kevin A. Carter director | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,625 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Hardik Mehta Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Mark Alan Miles Chief Compliance Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Gregory John Crawford President/CEO | DDisposition to issuer Common Sharesindirect: By Trust | -1,216,832 | $3.65 | $4.4M | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Thomas Roehrig Chief Accounting Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -50,000 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | David Bachelder Exec. VP Operations | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Brian Joseph Wessel director | DDisposition to issuer Stock Option (Right to Buy)derivative | -75,000 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Mark Alan Greenberg director | DDisposition to issuer Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Gregory John Crawford President/CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -75,000 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Mark Alan Miles Chief Compliance Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,000 | - | - | 0 | Mar 16, 2026 |
| Mar 16, 2026 | Thomas Roehrig Chief Accounting Officer | DDisposition to issuer Stock Options (Right to Buy)derivative | -30,000 | - | - | 0 | Mar 16, 2026 |
| Dec 5, 2025 | Gregory John Crawford President/CEO | MOption exercise Common Shares | +581,000 | $1.11 | $645k | 3,351,196 | Dec 15, 2025 |
| Dec 5, 2025 | Gregory John Crawford President/CEO | MOption exercise Common Sharesindirect: By Spouse | +2,500 | $1.11 | $2,775 | 22,500 | Dec 15, 2025 |
| Dec 5, 2025 | Gregory John Crawford President/CEO | MOption exercise Common Sharesderivative | -581,000 | $0.00 | $0 | 0 | Dec 15, 2025 |
| Dec 5, 2025 | Gregory John Crawford President/CEO | MOption exercise Common Sharesderivativeindirect: By Spouse | -2,500 | $0.00 | $0 | 0 | Dec 15, 2025 |
| Mar 22, 2025 | David Bachelder Exec. VP Operations | AGrant or award Common Shares | +20,000 | $0.00 | $0 | 22,156 | Mar 25, 2025 |
| Mar 22, 2025 | Kevin A. Carter director | AGrant or award Common Shares | +174,767 | $0.00 | $0 | 277,892 | Mar 25, 2025 |
| Mar 22, 2025 | Gregory John Crawford President/CEO | AGrant or award Common Shares | +936,000 | $0.00 | $0 | 2,770,196 | Mar 25, 2025 |
| Mar 22, 2025 | Patrick Dennis Gamble Exec. VP Operations | AGrant or award Common Shares | +20,000 | $0.00 | $0 | 60,057 | Mar 25, 2025 |
| Mar 22, 2025 | Mark Alan Greenberg director | AGrant or award Common Shares | +211,504 | $0.00 | $0 | 528,319 | Mar 25, 2025 |
| Mar 14, 2025 | Kevin A. Carter director | MOption exercise Common Shares | +53,124 | $0.00 | $0 | 103,125 | Mar 18, 2025 |
| Mar 14, 2025 | Gregory John Crawford President/CEO | MOption exercise Common Shares | +118,750 | $0.00 | $0 | 1,834,196 | Mar 18, 2025 |
| Mar 14, 2025 | Mark Alan Greenberg director | MOption exercise Common Shares | +115,625 | $0.00 | $0 | 316,815 | Mar 18, 2025 |
| Mar 14, 2025 | Kevin A. Carter director | MOption exercise Restricted Share Unitderivative | -53,124 | $0.00 | $0 | 0 | Mar 18, 2025 |
| Mar 14, 2025 | Mark Alan Greenberg director | MOption exercise Restricted Share Unitderivative | -115,625 | $0.00 | $0 | 0 | Mar 18, 2025 |
| Mar 14, 2025 | Gregory John Crawford President/CEO | MOption exercise Restricted Share Unitderivative | -118,750 | $0.00 | $0 | 0 | Mar 18, 2025 |
| Dec 26, 2024 | Patrick Dennis Gamble Exec VP Operations | POpen-market purchase Common Shares | +7,000 | $2.42 | $17k | 30,057 | Dec 30, 2024 |
| Dec 26, 2024 | Patrick Dennis Gamble Exec VP Operations | POpen-market purchase Common Shares | +10,000 | $2.47 | $25k | 40,057 | Dec 30, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- David BachelderExec. VP Operations
- Kevin A. Carterdirector
- Gregory John CrawfordPresident/CEO
- Patrick Dennis GambleExec. VP Operations
- Mark Alan Greenbergdirector
- Hardik MehtaChief Financial Officer
- Mark Alan MilesChief Compliance Officer
- Thomas RoehrigChief Accounting Officer
- Brian Joseph Wesseldirector
Questions about QIPT
Answered from the filings on this page, as of the latest one.
Are insiders buying QIPT?
No. In the last 90 days no insider at Quipt Home Medical Corp. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade QIPT on the open market?
Patrick Dennis Gamble (Exec VP Operations) bought $42k of QIPT on Dec 26, 2024 and filed the Form 4 on Dec 30, 2024. InsiderTell scored 31 (weak).
How many insiders file Form 4 at Quipt Home Medical Corp.?
9 people have filed a Form 4 at Quipt Home Medical Corp., among them David Bachelder (Exec. VP Operations), Kevin A. Carter (director), Gregory John Crawford (President/CEO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.